Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The shortage of deceased donor�s liver is the most significant factor inhibiting further application of liver transplantation for
patients with end stage liver disease. Several strategies were adopted around the world. Grafts from split livers constitute
an accepted approach to expand the donor pool. Over the last five years, most Argentinean centers have shown significant
interest in increasing the use of this technique. The purpose of this study was to describe and analyze the outcomes of right-side
grafts (RSGs) and left-side grafts (LSGs) from a multicenter study. The multicenter retrospective study included data from 111
recipients of SL grafts from between January 1, 2009 and December 31, 2013. Incidence of surgical complications, patient and
graft survival, and factors that affected RSG and LSG survival were analyzed. Grafts types were 57 LSG and 54 RSG. Median
follow-up times for LSG and RSG were 46 and 42 months, respectively. The 36-month patient and graft survivals for LSG were
83% and 79%, respectively, and for RSG were 78% and 69%, respectively. Re-transplantation rates for LSG and RSG were 3.5%
and 11%, respectively. Arterial complications were the most common cause of early re-transplantation (less than 12 months).
Cold ischemia time (CIT) longer than 10 hours and the use of high-risk donors (age 40 years or body mass index 30 kg/m2 or
five days intensive care unit stay) were independent factors for diminished graft survival in RSG. None of the analyzed variables
were associated with worse graft survival in LSG. Biliary complications were the most frequent complications in both groups
(57% in LSG and 33% in RSG). Partial grafts obtained from liver splitting are an excellent option for patients in need of liver
transplantation and have the potential to alleviate the organ shortage. Adequate donor selection and reducing CIT are crucial
for optimizing results.